1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)piperidine-2-carboxylic acid

Catalog No. :
ACLCPJ268
CAS No. :
1416371-93-1
Molecular Formula :
C13H21NO6
Molecular Weight :
287.31

IUPAC Name:1-(tert-butoxycarbonyl)-5-(methoxycarbonyl)piperidine-2-carboxylic acid

1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)piperidine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$261.00Login to see priceInquiryInquiry
1g95%$369.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)piperidine-2-carboxylic acid
IUPAC Name1-(tert-butoxycarbonyl)-5-(methoxycarbonyl)piperidine-2-carboxylic acid
MDL No.MFCD19690969
Molecular FormulaC13H21NO6
Molecular Weight287.31
SMILESO=C(C1N(C(OC(C)(C)C)=O)CC(C(OC)=O)CC1)O
InChI KeyAFVJQNPGRDLPCM-UHFFFAOYSA-N
Synonym1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)piperidine-2-carboxylic acid | 1416371-93-1 | SCHEMBL408875 | AKOS022176782 | P20813 | EN300-1589590 | 1-tert-butoxycarbonyl-5-methoxycarbonyl-piperidine-2-carboxylic acid | 1-[(tert-butoxy)carbonyl]-5-(methoxyca
CAS No.1416371-93-1
PubChem CID66678147

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLCPJ268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLCPJ268 route product structure diagram
    ACLCPJ2681416371-93-1
Inquiry

2. ACLCPJ268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLCPJ268 route product structure diagram
    ACLCPJ2681416371-93-1
Inquiry

Comments (0)